Press Releases
Path Fertility Awarded $2 Million NIH Grant to Develop Epigenetic Test for Severe Male Infertility and Associated Cancer Risk
Company also presents new data at ASRM 2026 showing sperm epigenetics predicts IUI success across clinics and physicians, and that sperm-derived cell-free DNA predicts sperm retrieval outcomes in men with azoospermia
By Inherent Biosciences Inc · Via ACCESS Newswire · October 26, 2026
Maven Expands From Meeting Intelligence to Matter Intelligence
Maven today announced a shift from legal meeting intelligence to AI-powered matter intelligence, with plans to connect matter documents, meeting records, and legal research in one platform. Client access is planned to begin in early 2027.
By Maven · Via Business Wire · October 26, 2026
Seagate Simplifies High-Capacity Storage Scaling for AI and Cloud Infrastructure
Seagate Technology (NASDAQ: STX) today announced a new interoperability milestone designed to simplify high-capacity storage expansion as AI and cloud workloads drive continued data growth.
By Seagate Technology Holdings plc · Via Business Wire · October 26, 2026
Ridge Security Is the Only Vendor Listed Across Four Categories in Three Gartner Cybersecurity Reports
Ridge Security, a leader in AI-powered offensive security and continuous security validation, has been included in four cybersecurity technology categories across three Gartner research reports, we believe it’s reflecting the growing focus on validating security defenses and identifying exposure before attackers can exploit it.
By Ridge Security · Via Business Wire · October 26, 2026
ZCCM : NOTICE OF EXTRAORDINARY GENERAL MEETING
Via Actus News · October 26, 2026
Globa Terra Acquisition Corporation Announces Revised Shareholder Extension Proposal, including $0.03 Per Share Payment for Redeeming and Non-Redeeming Shareholders Subject to Extension Approval and Funding
Company responds to shareholder concerns and seeks support for November 9 vote while advancing proposed Nature's Ledger business combinationGloba Terra targeting definitive Business Combination Agreement announcement during the month of November and pursuing transaction closing within approximately 180 days
By Globa Terra Acquisition Corp. · Via ACCESS Newswire · October 26, 2026
EZRA Launches Loop to Give Every Manager a Coach (and an AI That Knows When They Need One)
The first fully connected coaching experience pairs a dedicated ICF-accredited coach and Cai, an AI partner that remembers conversations, priorities and organizational context, so enterprises can develop their most critical performance layer: managers
By EZRA · Via ACCESS Newswire · October 26, 2026
Calmara Beverage Company Secures Retail Purchase Order from Keg N Bottle in San Diego
Physician-founded wellness beverage brand, supported by Fast Moving Consumer Goods' incubation platform, marks a major milestone in its retail expansion with Keg N Bottle stores in San Diego County.
By Fast Moving Consumer Goods, Inc. · Via ACCESS Newswire · October 26, 2026
Red Metal Defines 3-Kilometre Chargeability Trend Along Copper Gold Bearing Vein Structures at Carrizal
Vancouver, British Columbia--(Newsfile Corp. - October 26, 2026) - RED METAL RESOURCES LTD. (CSE: RMES) (OTC: RMESF) (FSE: I660) ("Red Metal" or the "Company") is pleased to report final results from the two-dimensional ("2D") and three-dimensional ("3D") induced polarization ("IP") and resistivity survey completed by Geophysical Studies Chile over its Carrizal Copper-Gold-Cobalt Property ("Carrizal" or the "Property"), near Vallenar in Chile's Atacama Region.
Via Newsfile · October 26, 2026
Gunnison Copper Officially Begins Trading on NYSE American Under Ticker "GUNN"
NYSE American debut expands access to U.S. investors as Gunnison advances its position as a growing American copper producer
Via Newsfile · October 26, 2026
AL-S Pharma Reports New AP-101 Phase 2 Weight Data and Outlines Phase 3 Clinical Trial in ALS at 2026 NEALS Annual Meeting
AL-S Pharma AG (“AL-S Pharma” or “the Company”), a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced new analyses from its global Phase 2 clinical trial (AP101-02) evaluating the company's Phase 3-ready lead program, AP-101, in patients with sporadic ALS and superoxide dismutase 1 (SOD1)-ALS. The new findings demonstrate greater preservation of body weight in patients treated with AP-101 compared with placebo. Weight loss has been associated with shorter survival, while longitudinal changes in weight may reflect several aspects of disease progression, including nutritional status, metabolic changes, and muscle loss.
By AL-S Pharma AG · Via Business Wire · October 26, 2026
Sable Offshore Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
Sable Offshore Corp. (the “Company”) (NYSE: SOC) today announced that it plans to release its third quarter 2026 financial and operating results before the market opens on Monday, November 9, 2026. The Company will host a conference call and webcast to discuss the results on the same day at 11:00 a.m. Eastern Time (10:00 a.m. Central Time).
By Sable Offshore Corp. · Via Business Wire · October 26, 2026
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Ethan Allen Shareholders Vote the WHITE Proxy Card “FOR” All Five of Doug Bergeron’s Director Nominees
Doug Bergeron, a significant shareholder of Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) with beneficial ownership, collectively with his affiliates and associates, of approximately 5.2% of Ethan Allen’s outstanding common stock, today announced that leading independent proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”) has recommended that Ethan Allen shareholders vote on the WHITE universal proxy card “FOR” ALL FIVE of his highly qualified director nominees to the Board of Directors (the “Board”) – Douglas G. Bergeron, Anna Brockway, Kristine E. Miller, Steve Oblak, and Stefanie Tsen Ward – at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on November 4, 2026.
By On Behalf of Doug Bergeron · Via Business Wire · October 26, 2026
Tutor Perini Announces Conference Call to Discuss Third Quarter 2026 Results
Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that it will host a conference call at 2:00 PM Pacific Time on Wednesday, November 4, 2026, to discuss the Company's third quarter 2026 results.
By Tutor Perini Corporation · Via Business Wire · October 26, 2026
Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company
BERKELEY HEIGHTS, N.J. and WESTFIELD, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Corxel Pharmaceuticals, Inc. (“Corxel US”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for obesity and related cardiometabolic conditions, and Amanat Acquisition Corp (Nasdaq: AMAN) (“Amanat”), a publicly traded special purpose acquisition company, today announced they have entered into a definitive business combination agreement.
By Amanat Acquisition Corp · Via GlobeNewswire · October 26, 2026
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Liberty Broadband Corporation Investors Who Received Charter Communications, Inc. (NASDAQ: CHTR) Shares in Connection with Charter Communications’ Acquisition of Liberty Broadband in August
SAN FRANCISCO, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former Liberty Broadband Corporation (“Liberty Broadband”) investors who received shares of Charter Communications, Inc. (“Charter” or the “Company”) in connection with Charter’s acquisition of Liberty Broadband on August 20, 2026 (“Merger”).
By Girard Sharp LLP · Via GlobeNewswire · October 26, 2026
Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress
MILLBRAE, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced the presentation of updated data for EIK1001 at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
By Eikon Therapeutics, Inc. · Via GlobeNewswire · October 26, 2026
Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP)
SAN FRANCISCO, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd., all national law firms specializing in complex class actions and shareholder rights, announce they have filed a class action lawsuit for violations of the federal securities laws against Compass, Inc. (“Compass” or “Company”) (NYSE: COMP) and certain officers and directors of Compass and Anywhere Real Estate Inc. (“Anywhere”). The class action asserts claims under Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 on behalf of former Anywhere shareholders who acquired newly issued Compass common stock in direct exchange for their Anywhere securities in the January 9, 2026 stock-for-stock transaction (the “Merger”) by which Compass merged with and acquired Anywhere (the “Class”). The case is pending in the United States District Court for the Southern District of New York and is captioned: Magloire v. Compass, Inc., et al., No. 1:26-cv-08885 (S.D.N.Y.).
By Girard Sharp LLP · Via GlobeNewswire · October 26, 2026
Aviatrix Launches Clearance to Limit What a Compromised Cloud Workload Can Reach, Without Breaking Production
Aviatrix Makes Clearance Free to Every Enterprise Through May 1, 2027, So Security Teams Have Time to Patch with a Containment Backstop in Place
By Aviatrix · Via GlobeNewswire · October 26, 2026
Where to Buy Mushroom Chocolate Bars: A Buyer’s Checklist
The mushroom chocolate market has attracted attention from consumers interested in specialty confectionery, botanical ingredients, and mushroom-based products. As more varieties appear in online searches, understanding the differences between formulations has become an important part of evaluating product quality.
Via BusinesNews Wire · October 26, 2026
Shroom Bars vs Shroom Gummies: Onset, Taste and Dosing
Mushroom-infused edibles have become an increasingly discussed category in the specialty confectionery market. Among the most recognizable formats are shroom bars and shroom gummies, which offer different textures, flavors, ingredients, and packaging styles.
Via BusinesNews Wire · October 26, 2026
Functional Mushroom Snacks: From Chocolate Bars to Gummies
Functional mushroom snacks are becoming a recognizable category in the specialty food and wellness market. From rich chocolate bars to fruit-flavored gummies, mushrooms are being incorporated into convenient snack formats that appeal to consumers interested in exploring new ingredients and food trends.
Via BusinesNews Wire · October 26, 2026
Atom Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Kidney Disease with Hyperuricemia
Atom Therapeutics, an innovative clinical-stage biotechnology company focused on the discovery and development of novel therapies for metabolic, inflammatory, and cardiovascular diseases, today announced that the first patient has been successfully dosed in its Phase 2 clinical trial evaluating lingdolinurad (ABP-671), for treatment of chronic kidney disease (CKD) with hyperuricemia. This Phase 2 clinical trial is being conducted in Australia and China.
By Atom Therapeutics Co., Ltd. · Via Business Wire · October 26, 2026
DHI Group, Inc. to Report Third Quarter Financial Results on November 4, 2026
DHI Group, Inc. (NYSE: DHX) ("DHI" or the "Company") today announced that it will report financial results for its third quarter ended September 30, 2026 on Wednesday, November 4, 2026, after the close of the market. Art Zeile, President and Chief Executive Officer, and Greg Schippers, Chief Financial Officer, will host a conference call and webcast at 5:00 pm Eastern Time to discuss the results.
By DHI Group, Inc. · Via Business Wire · October 26, 2026
Mimosa Tenuiflora Root Bark: Botanical Names and Bulk Textile Supply Planning
When textile makers research Mimosa tenuiflora root bark, understanding botanical names helps them compare bulk listings more accurately. From plant-based dye experiments to handmade fabric collections, textile makers often work with ingredients identified by scientific names, regional names, and commercial descriptions.
Via BusinesNews Wire · October 26, 2026
Choosing Mimosa Root Bark for Textile Crafts: Labels and Material Formats
Choosing Mimosa root bark for textile crafts starts with understanding its botanical name, plant part and physical format. For independent textile artists, natural dye enthusiasts, and small workshop owners, the quality of purchasing information can be just as important as the material itself.
Via BusinesNews Wire · October 26, 2026
Estimating Mimosa Root Bark Supply Needs Before Scaling a Dye Studio
Before expanding a dye studio’s Mimosa root bark inventory, estimate material needs from completed textile tests and planned production. The aim is to support a larger workload without tying up funds in unused supplies.
Via BusinesNews Wire · October 26, 2026
Host Movers Issues Moving Checklist for Melbourne and Western Suburbs
Family-owned removalist shares practical guidance on quotes, property access, packing and handover planning for households and businesses.
Via PRUnderground · October 26, 2026
Toobit lists TartSwap (TART) for spot trading
Toobit is pleased to announce the listing of TartSwap (TART) for spot
trading in the Innovation Zone.About TartSwap (TART)TartSwap is a self-custody platf
Via First Publisher · October 26, 2026
Leading Health Groups Redefine Heart Health for Girls and Women
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 26, 2026
Why Every Stage of Life Matters for a Woman's Heart Health
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 26, 2026
Sigma Introduces the "Sigma FP2": the Ultimate Full-Frame Step up for Visual Storytellers
Seamlessly Bridge the Gap Between Fine Art Photography and High-End Cinematography Without the Bulk
Via Newsfile · October 26, 2026
Joe Amara Executive Search Tapped to Lead Head of Power Origination Search
Joe Amara Executive Search has been selected by a large independent power producer to lead a confidential search for a Head of Power Origination. The executive will lead commercial strategy across a national wind, solar, and battery storage portfolio, with a central focus on attracting large-load customers and negotiating complex, long-term power agreements.
By Joe Amara Executive Search · Via Business Wire · October 26, 2026
Berkshire Hathaway Specialty Insurance Promotes Virginie Pelletier to Head of Executive & Professional Liability in France
Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has promoted Virginie Pelletier to Head of Executive & Professional Liability (E&P) in France.
By Berkshire Hathaway Specialty Insurance · Via Business Wire · October 26, 2026
Geogentia Launches Perimeter, Alerts-Only Threat Monitoring for Schools, Organizations, Family Offices and Places of Worship
Geogentia today launched Perimeter, threat monitoring for schools, organizations, family offices, public figures and places of worship. Perimeter finds threats posted online and sends an alert that says how serious each one is and exactly what to do about it.
By Geogentia · Via Business Wire · October 26, 2026
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer
MAINZ, Germany and SHANGHAI, China, October 26, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and DualityBiologics (Suzhou) Co., Ltd. (“DualityBio”, HKEX: 9606.HK) announced today that the DYNASTY-Breast02 global Phase 3 clinical trial (NCT06018337) met its primary endpoint demonstrating a statistically significant, yet modest improvement in progression-free survival (“PFS”) with trastuzumab pamirtecan (BNT323/DB-1303) compared to investigator’s choice of chemotherapy in chemotherapy-naïve patients with HR+/HER2-low metastatic breast cancer who have progressed on endocrine therapy. At this interim analysis for the secondary endpoint of overall survival (“OS”), data were not mature.
By BioNTech SE · Via GlobeNewswire · October 26, 2026
CoinW Partners with EngageLab to Fortify Global Trading Communications
SINGAPORE, Oct. 26, 2026 (GLOBE NEWSWIRE) -- EngageLab, an AI-first customer engagement platform, today announced its partnership with CoinW, one of the world's leading cryptocurrency trading platforms. Founded in 2017, CoinW provides a one-stop, intelligent trading experience for users worldwide. CoinW is integrating EngageLab’s AppPush, OTP, and Email capabilities into its transaction messaging infrastructure to support secure and reliable communications for its global user base.
By EngageLab · Via GlobeNewswire · October 26, 2026
HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
— ORPATHYS® plus TAGRISSO® reduced the risk of disease progression or death by 44% in the overall population and 55% in the high MET overexpression population in the first-line setting —
By HUTCHMED (China) Limited · Via GlobeNewswire · October 26, 2026
ET 2027 Puts SIVP to the Test at 2026 EXEED International User Summit
Wuhu, Anhui, China--(Newsfile Corp. - October 26, 2026) - From October 19 to 20, the 2026 EXEED International User Summit hosted its track experience days at Zhejiang International Circuit. There, EXEED put the ET 2027's Super Intelligent Valet Parking (SIVP) system to the test, giving guests a firsthand look at its capabilities. While acceleration, handling and braking were the focus of the on-track sessions, the SIVP demonstration shifted the spotlight to a more everyday aspect of driving: parking and vehicle pickup. By bringing cutting-edge technology to a familiar daily task, EXEED offered a practical demonstration of its vision for "Future Luxury," adding a distinctly real-world dimension to the summit theme, "The Pulse Lives on."
Via Newsfile · October 26, 2026
Bangkok pledges to put Asian LGBTQIA+ communities at the heart of WorldPride 2030
BANGKOK, THAILAND: BANGKOK, THAILAND – Media OutReach Newswire – 26 October 2026 – Bangkok has pledged to make WorldPride 2030 a platform for advancing LGBTQIA+ visibility an
Via MediaOutReach · October 26, 2026
ET 2027 Puts SIVP to the Test at 2026 EXEED International User Summit
Wuhu, Anhui, China, October 26, 2026 -- From October 19 to 20, the 2026 EXEED International User Summit hosted its track experience days at Zhejiang International Circuit. There, EXEED put the ET 2027’s Super Intelligent Valet Parking (SIVP) system to the test, giving guests a firsthand look at its capabilities. While acceleration, handling and braking were the focus of the on-track sessions, the SIVP demonstration shifted the spotlight to a more everyday aspect of driving: parking and vehicle pickup. By bringing cutting-edge technology to a familiar daily task, EXEED offered a practical demonstration of its vision for “Future Luxury,” adding a distinctly real-world dimension to the summit theme, “The Pulse Lives on.”
Via Press Release Distribution Service · October 26, 2026
Charles V. Pollack, MD, on Cardiometabolic Disease and siRNA Medications
The term "cardiometabolic disease" refers to a group of metabolic and cardiovascular conditions that dramatically raise a person's risk for heart attack, stroke, and type 2 diabetes. These conditions include hypertension, atherosclerotic disease (buildup of fatty deposits inside blood vessels), insulin resistance and obesity. While many of the conditions that…
Via PulseBulletin.com · October 26, 2026
Artexhi Moves Its Collection Platform onto Its Own Private Infrastructure, with Enclave
Collectors records, provenance and valuations now run on infrastructure that Artexhi owns and operates, designed to meet the security and compliance expectations of the private banks and family offices it works with.
Via Newsfile · October 26, 2026
Silver Pony Congratulates the British Columbia Conservative Party for Its Super Majority Provincial Government Win
Vancouver, British Columbia--(Newsfile Corp. - October 26, 2026) - Silver Pony Resources Corp. (CSE: PONY) (FSE: BJ40) (OTCID: PONIF) (formerly Carlyle Commodities Corp.) ("Silver Pony" or the "Company") is pleased to congratulate the British Columbia Conservative Party Government for its Super Majority victory in the Provincial Election which closed polls Saturday leaving the Conservatives with 64 of 93 seats and a Super Majority, the first for BC in over 100 years.
Via Newsfile · October 26, 2026
Honeywell Technologies Launches Forge Plant Cognition with Dangote, Built with NVIDIA AI and Dell Technologies Capabilities
Honeywell Technologies (NASDAQ: HON) has announced the launch of Forge Plant Cognition, an industrial AI platform built with NVIDIA AI and accelerated computing capabilities, and Dell Technologies’ AI infrastructure. The platform is designed to help refining, petrochemical and Liquefied Natural Gas (LNG) operators generate greater value from their existing assets and transform plant operations.
By Honeywell Technologies · Via Business Wire · October 26, 2026
Bitget Upgrades Stock Dual Investment with VETA Finance for Tokenized U.S. Equities
By Bitget Limited · Via GlobeNewswire · October 26, 2026
Phathom Pharmaceuticals Provides Update on FDA Litigation
FLORHAM PARK, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced the U.S. Food and Drug Administration’s (FDA’s) establishment of a public docket (Docket No. FDA-2026-N-13038) to solicit comment on legal and regulatory questions regarding certain issues raised by a filer of an abbreviated new drug application (ANDA) referencing VOQUEZNA® (vonoprazan) tablets, BDR Pharmaceuticals, International Pvt. Ltd. (BDR), in litigation brought against the FDA following FDA’s rejection of the ANDA. The litigation was brought to challenge FDA’s June 6, 2025 decision granting Phathom’s Citizen Petition, which agreed with Phathom that VOQUEZNA benefits from 10 years of New Chemical Entity (NCE) exclusivity through May 3, 2032. The deadline for comments submitted to the public docket is November 23, 2026.
By Phathom Pharmaceuticals · Via GlobeNewswire · October 26, 2026
FTI Consulting Adds Björn Storim to Strengthen Banking and Capital Markets Advisory in Germany
Former CEO of BNY’s European Bank brings decades of experience across financial services, regulation and strategic transformation
By FTI Consulting, Inc. · Via GlobeNewswire · October 26, 2026
PixVerse and OpenAI Collaborate on “Prompt to Production”, a New Learning Initiative for AI-Powered Creative Workflows
PixVerse and OpenAI announced Prompt to Production, a collaborative educational initiative designed to help people and teams using AI in their creative workflows. The initiative will show participants how to combine OpenAI frontier models and agentic capabilities with PixVerse’s multimodal generation tools.
By PixVerse · Via Business Wire · October 26, 2026
LBank Elevates Brand Identity, Built to Move Beyond Trading
By LBank · Via GlobeNewswire · October 26, 2026